Evidence for Molecular Mimicry between SARS‐CoV‐2 and Human Antigens: Implications for Autoimmunity in COVID‐19

Abstract

As for other viral diseases, the mechanisms behind the apparent relationship between COVID‐19 and autoimmunity are yet to be clearly defined. Molecular mimicry, the existence of sequence and/or conformational homology between viral and human antigens, could be an important contributing factor. Here, we review the accumulated evidence supporting the occurrence of mimicry between SARS‐CoV‐2 and human proteins. Both bioinformatic approaches and antibody cross‐reactions have yielded a significant magnitude of mimicry events, far more common than expected to happen by chance. The clinical implication of this phenomenon is ample since many of the identified antigens may participate in COVID‐19 pathophysiology or are targets of autoimmune diseases. Thus, autoimmunity related to COVID‐19 may be partially explained by molecular mimicry and further research designed specifically to address this possibility is needed.